Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dharamvir Jain

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2023
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.3Ishmael A Jaiyesimi, Dwight H Owen, Nofisat Ismaila, et al.
Clinical Breast Cancer|December 3, 2014
Efficacy of concurrent chemoradiotherapy for patients with locally recurrent or advanced inoperable breast cancerJoseph N Shaughnessy, Richard A Meena, Neal E Dunlap, et al.
Anticancer Research|March 4, 2025
Utilization and Outcomes of the 21-Gene Recurrence Score in pN2 Breast Cancer PatientsWaqar Haque, Vivek Verma, Niva Mangalampalli, et al.
American Journal of Clinical Oncology|March 8, 2013
Delay of adjuvant chemotherapy after elective mastectomy and immediate reconstruction in breast-conservation candidates: a matched-pair analysisParul N Barry, Elizabeth C Riley, Jianmin Pan, et al.
Breast Cancer Research and Treatment|June 8, 2019
Adherence to anti-estrogen therapy in women with hormone receptor-positive breast cancer utilizing bubble packaging: a pilot studyShruti Bhandari, Phuong Ngo, Blakely Kute, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2012
A phase 2 trial of once-weekly hypofractionated breast irradiation: first report of acute toxicity, feasibility, and patient satisfactionAnthony E Dragun, Amy R Quillo, Elizabeth C Riley, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2017
First Results of a Phase 2 Trial of Once-Weekly Hypofractionated Breast Irradiation (WHBI) for Early-Stage Breast CancerAnthony E Dragun, Nicholas J Ajkay, Elizabeth C Riley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2021
Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline UpdateHarold J Burstein, Mark R Somerfield, Debra L Barton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 11, 2015
Dectin-1 Activation by a Natural Product β-Glucan Converts Immunosuppressive Macrophages into an M1-like PhenotypeMin Liu, Fengling Luo, Chuanlin Ding, et al.
Oral Oncology|March 30, 2017
High-dose versus weekly cisplatin definitive chemoradiotherapy for HPV-related oropharyngeal squamous cell carcinoma of the head and neckCesar Augusto Perez, Xiaoyong Wu, Mark J Amsbaugh, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2023
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.3Ishmael A Jaiyesimi, Dwight H Owen, Nofisat Ismaila, et al.
Clinical Breast Cancer|December 3, 2014
Efficacy of concurrent chemoradiotherapy for patients with locally recurrent or advanced inoperable breast cancerJoseph N Shaughnessy, Richard A Meena, Neal E Dunlap, et al.
Anticancer Research|March 4, 2025
Utilization and Outcomes of the 21-Gene Recurrence Score in pN2 Breast Cancer PatientsWaqar Haque, Vivek Verma, Niva Mangalampalli, et al.
American Journal of Clinical Oncology|March 8, 2013
Delay of adjuvant chemotherapy after elective mastectomy and immediate reconstruction in breast-conservation candidates: a matched-pair analysisParul N Barry, Elizabeth C Riley, Jianmin Pan, et al.
Breast Cancer Research and Treatment|June 8, 2019
Adherence to anti-estrogen therapy in women with hormone receptor-positive breast cancer utilizing bubble packaging: a pilot studyShruti Bhandari, Phuong Ngo, Blakely Kute, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2012
A phase 2 trial of once-weekly hypofractionated breast irradiation: first report of acute toxicity, feasibility, and patient satisfactionAnthony E Dragun, Amy R Quillo, Elizabeth C Riley, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2017
First Results of a Phase 2 Trial of Once-Weekly Hypofractionated Breast Irradiation (WHBI) for Early-Stage Breast CancerAnthony E Dragun, Nicholas J Ajkay, Elizabeth C Riley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2021
Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline UpdateHarold J Burstein, Mark R Somerfield, Debra L Barton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 11, 2015
Dectin-1 Activation by a Natural Product β-Glucan Converts Immunosuppressive Macrophages into an M1-like PhenotypeMin Liu, Fengling Luo, Chuanlin Ding, et al.
Oral Oncology|March 30, 2017
High-dose versus weekly cisplatin definitive chemoradiotherapy for HPV-related oropharyngeal squamous cell carcinoma of the head and neckCesar Augusto Perez, Xiaoyong Wu, Mark J Amsbaugh, et al.
Pageof 3